Company Filing History:
Years Active: 2020
Title: Katia Bifulco: Innovator in Cancer Research
Introduction
Katia Bifulco is a prominent inventor based in Boscotrecase, Italy. She has made significant contributions to the field of cancer research, particularly in the development of innovative therapeutic strategies. Her work focuses on understanding and combating the metastatic process in tumors.
Latest Patents
Katia Bifulco holds a patent for "Retro-inverso peptide inhibitors of cell migration, extracellular matrix and endothelial invasion by tumor cells." This invention discloses retro-inverso peptides and pharmaceutical compositions that contain them. The peptides are designed to prevent key events during the metastatic process, such as the invasion of the extracellular matrix, the formation of a capillary network, and entry into the bloodstream. These innovations are particularly useful in treating diseases characterized by increased cell motility, cell invasion, and angiogenesis, including tumors and chronic inflammation. She has 1 patent to her name.
Career Highlights
Katia Bifulco is affiliated with the Istituto Nazionale Tumori Irccs “Fondazione G. Pascale,” where she conducts her research. Her work has garnered attention for its potential impact on cancer treatment and patient outcomes.
Collaborations
Katia collaborates with esteemed colleagues, including Maria Vincenza Carriero and Gennaro Ciliberto, to advance her research and explore new therapeutic avenues.
Conclusion
Katia Bifulco is a trailblazer in cancer research, with her innovative work on retro-inverso peptides paving the way for new treatment options. Her contributions are vital in the ongoing fight against cancer and its associated challenges.